APPLICATION
ANDA070737
TYPE
ANDA
ORIGINAL APPROVAL
1987-05-06
LATEST ACTION
2024-09-09
ROUTE
INTRAVENOUS
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription
Products
VERAPAMIL HYDROCHLORIDEPrescription
VERAPAMIL HYDROCHLORIDE 5MG/2ML (2.5MG/ML) · SOLUTION · INTRAVENOUS
VERAPAMIL HYDROCHLORIDEPrescription
VERAPAMIL HYDROCHLORIDE 10MG/4ML (2.5MG/ML) · SOLUTION · INTRAVENOUS
Approval history
2021-12-20Labeling · Supplement 25 · standardAP
2002-10-25Manufacturing (CMC) · Supplement 13AP
2001-03-22Manufacturing (CMC) · Supplement 12AP
2001-03-22Manufacturing (CMC) · Supplement 11AP
2000-01-07Labeling · Supplement 10AP
2000-01-07Manufacturing (CMC) · Supplement 9AP
1998-12-09Manufacturing (CMC) · Supplement 8AP
1998-03-26Labeling · Supplement 3AP
1996-10-22Manufacturing (CMC) · Supplement 5AP
1996-10-03Manufacturing (CMC) · Supplement 6AP
1991-04-17Labeling · Supplement 2AP
1990-05-17Manufacturing (CMC) · Supplement 1AP
1987-05-06OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.